| Abby Mccain Howenstein, | |
|
2231 W. Charleston Blvd., Las Vegas, NV 89102 | |
| (702) 383-2663 | |
| (702) 383-2682 |
| Full Name | Abby Mccain Howenstein |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 2231 W. Charleston Blvd., Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750709242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 20873 (Nevada) | Secondary |
| 207XP3100X | Orthopaedic Surgery - Pediatric Orthopaedic Surgery | 20873 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Center Of Southern Nevada | 7315934429 | 243 |
News Archive
Now, the University of Missouri Institute of Public Policy, Center for Health Policy and Missouri Telehealth Network are partnering with the Language Access Metro Project (LAMP) and the Missouri Primary Care Association to provide medical interpreters to non-English-speaking patients who otherwise might not have access to live interpreters.
With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.
A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
› Verified 4 days ago
| Entity Name | University Medical Center Of Southern Nevada |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548393127 PECOS PAC ID: 7315934429 Enrollment ID: O20040429001053 |
News Archive
Now, the University of Missouri Institute of Public Policy, Center for Health Policy and Missouri Telehealth Network are partnering with the Language Access Metro Project (LAMP) and the Missouri Primary Care Association to provide medical interpreters to non-English-speaking patients who otherwise might not have access to live interpreters.
With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.
A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
› Verified 4 days ago
| Entity Name | Optum Medical Group Rhodes P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063458594 PECOS PAC ID: 1052390036 Enrollment ID: O20040714000813 |
News Archive
Now, the University of Missouri Institute of Public Policy, Center for Health Policy and Missouri Telehealth Network are partnering with the Language Access Metro Project (LAMP) and the Missouri Primary Care Association to provide medical interpreters to non-English-speaking patients who otherwise might not have access to live interpreters.
With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.
A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abby Mccain Howenstein, 1800 W. Charleston Blvd., Las Vegas, NV 89102 Ph: (702) 383-2000 | Abby Mccain Howenstein, 2231 W. Charleston Blvd., Las Vegas, NV 89102 Ph: (702) 383-2663 |
News Archive
Now, the University of Missouri Institute of Public Policy, Center for Health Policy and Missouri Telehealth Network are partnering with the Language Access Metro Project (LAMP) and the Missouri Primary Care Association to provide medical interpreters to non-English-speaking patients who otherwise might not have access to live interpreters.
With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.
A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.
› Verified 4 days ago
William Ralston Mcgee Ii, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9159 W Flamingo Rd Ste 100, Las Vegas, NV 89147 Phone: 024-855-8857 Fax: 888-593-7092 | |
Erik Noble Kubiak, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2231 West Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2663 Fax: 702-383-2682 | |
Dr. Victor Hoang, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-8436 | |
Dr. Edward Ratcliffe Anderson Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4750 W Oakey Blvd Ste 2b, Las Vegas, NV 89102 Phone: 702-579-3297 Fax: 702-796-2302 | |
Bradley Scott Baker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave, #160, Las Vegas, NV 89128 Phone: 702-878-0393 Fax: 702-933-0637 | |
Hugh S Selznick, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3006 S Maryland Pkwy, 570, Las Vegas, NV 89109 Phone: 702-777-2663 Fax: 702-777-0030 | |
Ronald W. Hillock, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave, #160, Las Vegas, NV 89128 Phone: 702-878-0393 Fax: 702-258-5564 |